Toxicogenomic assessment of in vitro macrophages exposed to profibrotic challenge reveals a sustained transcriptomic immune signature

Jack Morikka,Antonio Federico,Lena Möbus,Simo Inkala,Alisa Pavel,Saara Sani,Maaret Vaani,Sanna Peltola,Angela Serra,Dario Greco
DOI: https://doi.org/10.1016/j.csbj.2024.10.010
IF: 6.155
2024-10-10
Computational and Structural Biotechnology Journal
Abstract:Immune signalling is a crucial component in the progression of fibrosis. However, approaches for the safety assessment of potentially profibrotic substances, that provide information on mechanistic immune responses, are underdeveloped. This study aimed to develop a novel framework for assessing the immunotoxicity of fibrotic compounds. We exposed macrophages in vitro to multiple sublethal concentrations of the profibrotic agent bleomycin, over multiple timepoints, and generated RNA sequencing data. Using a toxicogenomic approach, we performed dose-dependent analysis to discover genes dysregulated by bleomycin exposure in a dose-responsive manner. A subset of immune genes displayed a sustained dose-dependent and differential expression response to profibrotic challenge. An immunoassay revealed cytokines and proteinases responding to bleomycin exposure that closely correlated to transcriptomic alterations, underscoring the integration between transcriptional immune response and external immune signalling activity. This study not only increases our understanding of the immunological mechanisms of fibrosis, but also offers an innovative framework for the toxicological evaluation of substances with potential fibrogenic effects on macrophage signalling. Our work brings a new immunotoxicogenomic direction for hazard assessment of fibrotic compounds, through the implementation of a time and resource efficient in vitro methodology. Graphical Download: Download high-res image (163KB) Download: Download full-size image Lung fibrosis is driven in part by an excessive immune reaction mediated by macrophages. This study develops a framework to assess the effect of profibrotic exposure on the immune signature of fibrotically activated macrophages. THP-1 macrophage cells were exposed in-vitro to 0–100 μg/mL of bleomycin. RNA sequencing and cytokine immunoassays were performed and analysed using dose-dependent modelling. Correlation of gene expression to cytokine expression revealed genes likely to be controlling cytokine expression. Immune gene filtering of both the RNA sequencing analysis and the correlation analysis reveals a distinct immune gene expression signature in response to bleomycin, sustained across timepoints.
biochemistry & molecular biology
What problem does this paper attempt to address?